Diabetes Stock Insulet Pops on Earnings Beat and Guidance Raise
Insulet (NASDAQ: PODD) reported strong third-quarter 2019 results after the market closed on Tuesday, Nov. 5. The tubeless insulin pump specialist's revenue grew 27% and its adjusted earnings per share surged 200% year over year.
Shares of the Massachusetts-based healthcare company jumped 3.3% in after-hours trading on Tuesday. We can attribute the market's initial reaction to both revenue and adjusted earnings surpassing Wall Street's consensus estimates, along with management increasing its full-year 2019 revenue guidance. In 2019, shares have gained 86.6% through Tuesday's regular trading session, versus the S&P 500's 24.8% return.
(Insulet stock is one of just three stocks highlighted in last month's "3 Stocks Poised for Huge Growth Over the Next Decade.")
Source Fool.com
